"It's nothing that the dupilumab is doing, it's that the dupilumab's allowing you to avoid prednisone and high-dose topical steroids, which cause modest growth inhibition," he told MedPage Today. The ...

Dupilumab is safe and efficacious for the treatment of atopic dermatitis for 3 years among pediatric patients aged 6 months to 11 years.

Eczema can be managed with certain self-care ... or mycophenolate mofetil Biologic agents, such as dupilumab (Dupixent) or lebrikizumab-lbkz (Ebglyss), are reserved for people who have tried ...

The Food and Drug Administration (FDA) has approved four biologics to treat eczema: Dupilumab (Dupixent) was the first FDA-approved medication. It is a monoclonal antibody that targets interleukin ...

A patient has eczema and bad asthma, a certain type of asthma, well, Dupilumab's FDA approved to treat both. You might be able to kill two birds with one stone. Patient has really bad vernal ...

Lebrikizumab is comparable or superior to many advanced systemic monotherapies for the short-term treatment of atopic dermatitis.

Eczema is an umbrella term for a group of conditions ... This class of drugs — such as dupilumab (Dupixent) — targets specific parts of the immune system, like certain proteins involved ...

Further, associations between dupilumab and reduced risks for anxiety ... by Lin et al as the relationship of mental health and eczema treatment is an important one for the NEA [National Eczema ...

News release, FDA. News release, National Eczema Association. Journal of the American Academy of Dermatology: "Dupilumab shows long-term safety and efficacy in patients with moderate to severe ...

"It's nothing that the dupilumab is doing, it's that the dupilumab's allowing you to avoid prednisone and high-dose topical steroids, which cause modest growth inhibition," he told MedPage Today.